It is speculated that blood thinning drugs like aspirin might help patients with congestive heart failure , but there has been no rigorous research to help doctors define the precise role for such treatment. CSP is planning a study of a number of blood thinning drugs in patients with heart failure to provide answers to this important treatment question. Many patients with schizophrenia don't respond well to conventional treatments, and newer drugs that are both safe and effective are needed. CSP is planning a trial of a promising new medication to see if it helps improve symptoms and functioning in patients with refractory schizophrenia. The study will also evaluate the drug's cost-effectiveness.
Sleep apnea is a condition in which patients periodically stop breathing while they are asleep.
This is especially serious in patients who also have congestive heart failure . CSP is planning a study in patients with both heart failure and sleep apnea that will determine if medication or oxygen treatment aimed at improving the apnea will also improve heart failure, preventing hospitalizations and death. It is known that for patients who have just had surgery, medication helps to prevent clots. However, it is not known if patients who are in the hospital for reasons other than surgery will be helped by medication intended to prevent blood clots. CSP is planning a study of 31,000 hospitalized patients to determine if treatment with a blood thinning drug is effective and safe enough to warrant wide-spread use to prevent blood clots.